CG001（CorrGene）

N/A

Report date: 2023/03/14 11:07:38

Base Information

Drug NameCG001（CorrGene）
Drug Alias NameCG001（ Kejin Bio）CG001（ Wuxi Kejin Biotechnology ）CG001CG-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionPyruvate kinase isozymes R/L agonists
TargetsPyruvate kinase isozymes R/L
Therapy Area/IndicationsPyruvate kinase deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Kejin Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Kejin Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPyruvate kinase deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A